PLD
38
-7
XOM
54
-2
MET
50
3
SRE
45
3
AMG
75
4
BMY
41
4
CMS
50
2
NRG
44
-8
URBN
55
3
NEM
48
-2
ALL
40
-3
PM
45
-5
AN
43
-6
AIZ
68
4
HAS
64
4
XYL
62
6
ZTS
31
-2
PRU
59
2
QCOM
55
-2
HP
33
3
PLD
38
-7
XOM
54
-2
MET
50
3
SRE
45
3
AMG
75
4
BMY
41
4
CMS
50
2
NRG
44
-8
URBN
55
3
NEM
48
-2
ALL
40
-3
PM
45
-5
AN
43
-6
AIZ
68
4
HAS
64
4
XYL
62
6
ZTS
31
-2
PRU
59
2
QCOM
55
-2
HP
33
3
Financhill
Back

Heron Therapeutics 10K Form

Sell
21

HRTX
Heron Therapeutics

Last Price:
$1.93
Seasonality Move:
-11.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRTX News And Ratings

See the #1 stock for the next 7 days that we like better than HRTX

HRTX Financial Statistics

Sales & Book Value

Annual Sales: $144.3M
Cash Flow: $-9M
Price / Cash Flow: 0
Annual Sales: $-0.19
Price / Book: 0

Profitability

EPS (TTM): -0.05000
Net Income (TTM): $-7.8M
Gross Margin: $105.6M
Return on Equity: 0%
Return on Assets: -3.46%

Heron Therapeutics Earnings Forecast

Key Heron Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 38 years for HRTX is 73.21%.
  • The Selling, General & Administrative Expenses for HRTX have been equal to 69.64% of Gross Profit Margin.
  • The Research & Development expenses have been 11.56% of Revenue.
  • The Net Earning history of HRTX is -9.41% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 21 years.

Heron Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: HRTX
CUSIP: 427746
Website: herontx.com

Debt

Debt-to-Equity Ratio: -6.15
Current Ratio: 2.4
Quick Ratio: 1.46

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 44.44

HRTX Technical Analysis vs Fundamental Analysis

Sell
21
Heron Therapeutics (HRTX) is a Sell

Is Heron Therapeutics a Buy or a Sell?